We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
Anti-abortion activists hold signs calling for the Supreme Court justices to "affirm the decision of Federal District Court Judge Matthew Kacsmaryk who suspended the Food and Drug Administration's approval of Mifepristone," in front of the U.S. Supreme Court in Washington, U.S., April 21, 2023.
The US Supreme Court has agreed to hear arguments over legal challenges to the availability of mifepristone, a pill used in about half of all abortions provided in the United States.
The Federal Drug Administration approved the drug for use two decades ago, but in November 2022, a group of anti-abortion medical organizations filed a lawsuit claiming the FDA had no legal right to do that. A ruling is expected by the end of June.
It’s hard to imagine an upcoming Supreme Court ruling with greater election-year political impact. Democrats know that a majority of independent US voters favor legal access to abortion. In addition, young voters, whose support will be crucial for President Joe Biden’s reelection campaign, strongly favor abortion access and have voted in the past to protect it.
Politically, any landmark ruling on abortion is a win for Biden and Democrats, who believe this issue motivates their voter base to turn out on Election Day. Republicans hope the election is decided on questions like inflation and immigration where their messaging is more broadly popular.